Velvet Therapeutics
PrivateLast Round
VC Round
Sep 18, 2023
Total Funding Raised
$1.62M
Company Overview
Velvet Therapeutics operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a VC Round in September 2023.
Velvet Therapeutics is a biotechnology company developing gene therapies intended to treat rare cancers and autoimmune diseases using a proprietary non-viral, in vivo CAR platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Velvet Therapeutics Comparables
Compare Velvet Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aera Therapeutics | 86% | |
| Ensoma | 79% | |
| Eli Lilly and Company | 78% |
For institutional investors. Book with your work email.
Velvet Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 18, 2023 | ||||
| Debt | Aug 28, 2023 | ||||
| Seed | Jan 11, 2021 |
For institutional investors. Book with your work email.
Velvet Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BCM Ventures | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 18, 2023
Raised $2M from BCM Ventures.
- Aug 28, 2023
$500K debt round completed.
For institutional investors. Book with your work email.
Velvet Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Velvet Therapeutics's valuation, stock price, and market status.
Is Velvet Therapeutics a public or private company?
Velvet Therapeutics is a private company.
What is the current stock price of Velvet Therapeutics?
Velvet Therapeutics is a private company, so its shares have no public market price. Caplight tracks Velvet Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Velvet Therapeutics worth (valuation)?
Valuation information for Velvet Therapeutics is not publicly available.
Can I buy Velvet Therapeutics stock?
Velvet Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Velvet Therapeutics's last funding round?
Velvet Therapeutics's most recent funding round was VC Round on September 18, 2023.
Who are the main investors in Velvet Therapeutics?
Key investors in Velvet Therapeutics include BCM Ventures.
Will Velvet Therapeutics IPO soon?
No public IPO plans have been announced for Velvet Therapeutics.
How can I track Velvet Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Velvet Therapeutics's shares on secondary markets.